Correlation Between Dupont De and Nabriva Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dupont De and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Nabriva Therapeutics AG, you can compare the effects of market volatilities on Dupont De and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Nabriva Therapeutics.
Diversification Opportunities for Dupont De and Nabriva Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dupont and Nabriva is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Nabriva Therapeutics go up and down completely randomly.
Pair Corralation between Dupont De and Nabriva Therapeutics
If you would invest 7,071 in Dupont De Nemours on August 29, 2024 and sell it today you would earn a total of 1,327 from holding Dupont De Nemours or generate 18.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Dupont De Nemours vs. Nabriva Therapeutics AG
Performance |
| Timeline |
| Dupont De Nemours |
| Nabriva Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Dupont De and Nabriva Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Nabriva Therapeutics
The main advantage of trading using opposite Dupont De and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.| Dupont De vs. Direxion Daily FTSE | Dupont De vs. Collegium Pharmaceutical | Dupont De vs. KKR Co LP | Dupont De vs. iShares Dividend and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |